ACURASTEM
AcuraStem is a startup company that was formed in 2016 to create an innovative precision medicine platform. They are a team of PhDs, professors, tech entrepreneurs, and successful drug company veterans employing the latest scientific breakthroughs to address one of the most challenging, but they believe tractable, health problems of their time —Amyotrophic Lateral Sclerosis (ALS). AcuraStem harnesses advanced cellular reprogramming and artificial intelligence technologies to transform the standard of care for neurodegenerative diseases through patient-specific treatment.
ACURASTEM
Industry:
Artificial Intelligence (AI) Biotechnology Health Care Health Diagnostics Medical Neuroscience Therapeutics
Founded:
2016-01-01
Address:
Monrovia, California, United States
Country:
United States
Website Url:
http://www.acurastem.com
Total Employee:
11+
Status:
Active
Contact:
+1 213-290-0635
Email Addresses:
[email protected]
Total Funding:
12 M USD
Technology used in webpage:
Facebook Sharer U.S. Server Location COVID-19
Similar Organizations
Akili Interactive Labs
Akili is a digital therapeutics company that offers Innovative video game-based therapies for neurological and psychiatric conditions.
Emedgene
Emedgene provides data-driven AI solutions for genomic diagnostics and discovery at scale.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
humm
humm harnesses cutting-edge neuroscience into products that allow people to learn faster and perform better.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - AcuraStem
U.S. Department of Defense
U.S. Department of Defense investment in Grant - AcuraStem
Congressionally Directed Medical Research Programs
Congressionally Directed Medical Research Programs investment in Grant - AcuraStem
Keiretsu Forum
Keiretsu Forum investment in Convertible Note - AcuraStem
Viva Biotech
Viva Biotech investment in Convertible Note - AcuraStem
Small Business Innovation Research
Small Business Innovation Research investment in Grant - AcuraStem
Official Site Inspections
http://www.acurastem.com Semrush global rank: 8.98 M Semrush visits lastest month: 445
- Host name: 157.230.200.146
- IP address: 157.230.200.146
- Location: North Bergen United States
- Latitude: 40.793
- Longitude: -74.0247
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07047
More informations about "AcuraStem"
About - Acurastem
AcuraStem is an LA-based biotechnology company employing cutting-edge technology in its efforts to find effective treatments for neurodegenerative diseases. AcuraStem’s team of …See details»
AcuraStem - Crunchbase Company Profile & Funding
AcuraStem is a startup company that was formed in 2016 to create an innovative precision medicine platform. They are a team of PhDs, professors, tech …See details»
AcuraStem - LinkedIn
AcuraStem is delivering high-impact ALS therapeutics. Join us at the Neuroscience Innovation Pharma Partnering Summit in Boston (Feb 18-19), where CSO Marcel van der Brug will showcase the ...See details»
AcuraStem, Inc. - Drug pipelines, Patents, Clinical trials
Feb 27, 2025 AcuraStem is a startup company that was formed in 2016 to create an innovative precision medicine platform. They are a team of PhDs, professors, tech entrepreneurs, and successful drug company veterans …See details»
AcuraStem 2025 Company Profile: Valuation, Funding …
AcuraStem General Information Description. Developer of a precision medicine platform designed to model patient tissues in the laboratory. The company's platform evaluates the progression of disease and tests existing food and drug …See details»
AcuraStem Incorporated | Alzheimer's Drug Discovery …
May 3, 2021 Thus, AcuraStem is developing a therapeutic to suppress PIKFYVE. Our research has shown that suppression of PIKFYVE helps prevent degeneration of patient neurons in a dish, and strongly prevents loss of motor …See details»
AcuraStem - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 28, 2025 AcuraStem is a seed company based in Monrovia (United States), founded in 2016 by Qing Liu, Justin Ichida, Paul August and Sam Alworth. It operates as a Developer of …See details»
AcuraStem, Inc. (AcuraStem, Inc.) - 药物管线_专利_临床 …
PASADENA, Calif., Sept. 3, 2024 /PRNewswire/ -- AcuraStem, a patient-based biotechnology company advancing treatments for amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurodegenerative …See details»
AcuraStem - Funding, Financials, Valuation & Investors - Crunchbase
AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS. New. Resources. ... How much funding has …See details»
AcuraStem Inc. - VentureRadar
" AcuraStem is a patient-based biotechnology company that specializes in advancing treatments for neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), frontotemporal …See details»
AcuraStem - Contacts, Employees, Board Members, Advisors
Organization. AcuraStem . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Number of Board Member and Advisor Profiles 1. …See details»
AcuraStem - app.biopharmiq.com
About: AcuraStem (acurastem.com) is a near-to-clinic, patient-based, drug development company pioneering drug discovery and ultimately how treatments are developed for neurodegenerative …See details»
AcuraStem Secures $7 Million in Funding Support from NIH and …
Jan 30, 2024 AcuraStem Leverages iNeuroRx® Platform to Drive Innovative SYF2 and UNC13A Treatments Forward Toward Clinical Trials ... is an independent 501(c)(3) not-for-profit …See details»
AcuraStem - Company info. interviews, news - BiopharmaTrend
AcuraStem is a fast growing startup company that was formed in 2016 to create an innovative precision medicine platform. We are a team of PhDs, professors, tech entrepreneurs, and …See details»
AcuraStem Secures $7 Million in Funding Support from NIH and …
Jan 30, 2024 AcuraStem's research is funded in part by support from the Alzheimer's Drug Discovery Foundation, Harrington Discovery Institute, Alzheimer's Association, Rainwater …See details»
Takeda joins PIKfyve ALS push with AcuraStem deal
Apr 13, 2025 Takeda is paying up to $580 million for exclusive global rights to AcuraStem’s lead PIKfyve drug AS-202, an antisense oligonucleotide, as well as follow-up candidates for ALS …See details»
AcuraStem - Tech Stack, Apps, Patents & Trademarks - Crunchbase
AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS. New. Resources. Advanced Search. Start …See details»
DNA organization offers clues for advancing stem cell therapy
3 days ago Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power. The researchers demonstrate in a paper published in the …See details»
News & Events :: Acurastem
AcuraStem has been awarded a $225 thousand Phase I SBIR grant by the National Institute on Aging (NIA), part of the National Institutes of Health. The grant will fund continued research of …See details»
AcuraStem Secures $7 Million in Funding Support from NIH and …
Jan 30, 2024 AcuraStem Leverages iNeuroRx® Platform to Drive Innovative SYF2 and UNC13A Treatments Forward Toward Clinical Trials. PASADENA, Calif., January 30, 2024 — …See details»